UMB Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
UMB Bank's NVS Position: Q1 2026 in Review
UMB Bank reduced its Novartis (NVS) stake by 0.16% in Q1 2026, selling an estimated $1.69K and leaving 6,664 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #357.
UMB Bank first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.23M in Q2 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- UMB Bank held 6,664 shares of Novartis worth $1.02M as of Q1 2026.
- UMB Bank sold 11 Novartis shares in Q1 2026, an estimated $1.69K.
- Novartis made up 0.01% of UMB Bank's portfolio in Q1 2026, its #357 holding.
- UMB Bank first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
- UMB Bank's Novartis position peaked at $1.23M in Q2 2023.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.